Iwata S, Yokota T, Kusumoto Y, Shiro H, Sato Y, Akita H, Nanri S, Oikawa T, Kusano S, Sunakawa K
Jpn J Antibiot. 1986 Aug;39(8):1967-74.
Influence of cefroxadine (CXD) dry syrup on intestinal bacterial flora was studied in mice infected with 4 species of bacteria, namely, Escherichia coli, Enterococcus faecalis, Bacteroides fragilis and Bifidobacterium breve, and in pediatric patients having infections in the respiratory tract and cutaneous/soft tissues. The results were summarized as follows: CXD dry syrup was administered for 5 consecutive days to mice infected with the 4 species. No considerable changes were observed in levels of bacteria in the feces and in different parts of digestive tracts. Eleven pediatric patients were orally administered with 30-54 mg/kg of CXD dry syrup a day for 7-15 consecutive days. Symptom of diarrhea was noted in 2 patients. Dominant species of the intestinal flora such as E. coli, Bifidobacterium, and Bacteroides sometimes decreased in patients treated with CXD dry syrup. In general, however, decreases in numbers of these bacteria were insignificant. Changes of intestinal flora in patients treated with CXD dry syrup were apparently smaller than those treated with ampicillin and were similar to those treated with cephalexin or amoxicillin.
研究了头孢沙定(CXD)干糖浆对感染4种细菌(即大肠杆菌、粪肠球菌、脆弱拟杆菌和短双歧杆菌)的小鼠以及患有呼吸道和皮肤/软组织感染的儿科患者肠道细菌菌群的影响。结果总结如下:对感染这4种细菌的小鼠连续5天给予CXD干糖浆。在粪便和消化道不同部位的细菌水平未观察到明显变化。11名儿科患者每天口服30 - 54 mg/kg的CXD干糖浆,连续7 - 15天。2名患者出现腹泻症状。在接受CXD干糖浆治疗的患者中,肠道菌群的优势菌如大肠杆菌、双歧杆菌和拟杆菌有时会减少。然而,总体而言,这些细菌数量的减少并不显著。接受CXD干糖浆治疗的患者肠道菌群的变化明显小于接受氨苄西林治疗的患者,与接受头孢氨苄或阿莫西林治疗的患者相似。